Company Overview of Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. develops immunotherapies. Its products include Anti-CCR4 antibody for the treatment of cancer, IL-35 antagonists for the treatment of cancer, and IL-35 agonists for the treatment of autoimmune diseases. The company was incorporated in 2014 and is based in South San Francisco, California.
601 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2014
Key Executives for Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
To contact Tizona Therapeutics, Inc., please visit tizonatx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.